Prothena Corporation plc (PRTA)
NASDAQ·Healthcare·Biotechnology
$8.75
—
Mkt Cap $436.37M
Analyst Ratings
No recent rating data.
Price Target (15 analysts)
$30.00
Range $30.00 – $30.00
Implied Upside
+242.9%
Consensus $30.00 vs current $8.75
NASDAQ·Healthcare·Biotechnology
$8.75
—
Mkt Cap $436.37M
No recent rating data.
Price Target (15 analysts)
$30.00
Range $30.00 – $30.00
+242.9%
Consensus $30.00 vs current $8.75